Search filters

List of works by Simon Hogg

A method to investigate the anti-metabolic activity of anti-cancer agents on ovarian cancer cells cultured in a 96-well high throughput format

scientific article published on 4 July 2015

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

scientific article published on 12 July 2016

BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

scientific article

CDK13 cooperates with CDK12 to control global RNA polymerase II processivity

scientific article published on 29 April 2020

Data from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Data from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ.

scientific article published on 11 August 2016

Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

scientific article published in 2022

Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

scientific article published in 2022

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

scientific article published on 22 April 2022

Resveratrol, Acetyl-Resveratrol, and Polydatin Exhibit Antigrowth Activity against 3D Cell Aggregates of the SKOV-3 and OVCAR-8 Ovarian Cancer Cell Lines

scientific article

Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Supplementary Table S1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Supplementary Table S1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Supplementary Video Legends and Figures from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

scientific article published on 01 May 2021

Targeting the epigenetic regulation of antitumour immunity

scientific article published on 14 September 2020

Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and Differentiation

scientific article published on 01 October 2020

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

scientific article published on 17 May 2021

The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound

scientific article

The natural function of the malaria parasite's chloroquine resistance transporter

scientific article published on 06 August 2020

Tumor immune evasion arises through loss of TNF sensitivity

scientific article published on 01 May 2018

Video 1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 1 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 2 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 2 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 3 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 4 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Video 4 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity

Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

scientific article published on 30 December 2020

Paulina is supported by:

About Paulina

Help